Efficacy of early initiation of vericiguat in acute heart failure: a prospective study

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Junlong Chen

Center for Translational and Experimental Cardiology (CTEC), Zurich (Switzerland)

6 More presentations in this session

Presentation thumbnail

Impact of QRS duration on drug titration and left ventricular recovery in new-onset heart failure with reduced ejection fraction

Doctor A. Arenas Loriente (Barcelona, ES)

Abstract Slides Video

Presentation thumbnail

A decision algorithm for palliative care initiation in heart failure patients

Doctor I. Santos (Ponta Delgada, PT)

Abstract Slides Video

Presentation thumbnail

The efficacy and safety of hydroxychloroquine in patients with chronic inflammatory cardiomyopathy after fulminant myocarditis: a multicenter randomized study of the HYPIC trial

Doctor W. He (Wuhan, CN)

Abstract Slides Video

Presentation thumbnail

Effects of a dyadic empowerment-based heart failure management program (De-HF) on patient-reported and clinical outcomes: a double-blind randomized controlled trial

Doctor D. Yu (Hong Kong, HK)

Abstract Slides Video

Presentation thumbnail

Vutrisiran reduces days lost to death and/or hospitalization versus placebo in patients with transthyretin amyloidosis with cardiomyopathy in the HELIOS-B trial

Doctor M. Hanna (Cleveland, US)

Abstract Slides Video

Access the full session

Session thumbnail

Multidisciplinary care in heart failure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Use of vericiguat: real-world outcomes and insights from the VERITA registry.

Congress Session

HOT LINE 2

Congress Session

Pharmacotherapy for worsening heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources